false
0001468929
0001468929
2025-11-21
2025-11-21
0001468929
NXGL:CommonStockParValue0.001Member
2025-11-21
2025-11-21
0001468929
NXGL:WarrantsToPurchaseCommonStockMember
2025-11-21
2025-11-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 21, 2025
| NEXGEL,
INC. |
| (Exact
name of registrant as specified in its charter) |
| Delaware |
|
001-41173 |
|
26-4042544 |
| (State
or other jurisdiction |
|
(Commission
File Number) |
|
(IRS
Employer |
| of
incorporation) |
|
|
|
Identification
No.) |
2150
Cabot Boulevard West, Suite B
Langhorne,
Pennsylvania |
|
19047 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (215) 702-8550
(Former
name or former address, if changed since last report)
Not
Applicable
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None
| Title
of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which
registered |
| Common Stock, par value
$0.001 |
|
NXGL |
|
The Nasdaq Capital Market
LLC |
| Warrants to Purchase Common
Stock |
|
NXGLW |
|
The Nasdaq Capital Market
LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
8.01 Other Events
On
November 21, 2025, the Board of Directors (the “Board”) of NexGel, Inc. (the “Company”)
voted, pursuant to Section 2.3 of the Company’s Amended and Restated Bylaws, to cancel the Special Meeting of Stockholders scheduled
to be held at 10 a.m. Eastern Time on November 26, 2025 (the “Special Meeting”). The Board originally called
the Special Meeting to vote to approve a proposal, if and only if the Board approves and implements, an amendment to the Company’s
Amended and Restated Certificate of Incorporation, to increase the total number of authorized shares of the Company’s common stock,
par value $0.001 per share, from 25,000,000 to 1,000,000,000 (the “Proposal”) as more fully described in the
Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on October 30, 2025. As such, the Board
and the Company will not be pursuing the approval by the Company’s stockholders of the Proposal.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit |
|
|
| No. |
|
Description |
| |
|
|
| 104 |
|
Cover Page Interactive Data File (formatted as Inline
XBRL) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Date: November 24, 2025 |
|
|
| |
|
|
|
| |
|
NEXGEL, INC. |
| |
|
|
|
| |
|
By: |
/s/
Adam Levy |
| |
|
|
Adam Levy |
| |
|
|
Chief Executive Officer |